StockWatch
·
Pharmaceuticals
Board Meeting23 Apr 2026, 07:51 pm

Biocon Board to meet May 7 for Q4/FY26 results & dividend

AI Summary

Biocon Ltd has announced that its Board of Directors will convene on Thursday, May 7, 2026. The primary agenda for this meeting is to approve and take on record the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Additionally, the Board will consider the recommendation of a dividend, if any. In compliance with insider trading regulations, the trading window for the company's securities has been closed from April 1, 2026, to May 9, 2026, and will reopen on May 10, 2026. The company will also host an Earnings Conference Call for analysts and investors on Friday, May 8, 2026, at 09:00 hrs IST to discuss the results.

Key Highlights

  • Board meeting scheduled for May 7, 2026, to approve Q4/FY26 financial results.
  • Board will consider recommendation of dividend, if any, for the financial year.
  • Earnings conference call for analysts and investors set for May 8, 2026.
  • Trading window for company securities is closed from April 1 to May 9, 2026.